肾内科指南

订阅

MedSci主页 / 所有栏目 / 肾内科指南

2022 AAST临床共识：横纹肌溶解症

2022-01-27 美国创伤外科协会 Trauma Surg Acute Care Open

横纹肌溶解症

2022年1月，美国创伤外科协会(AAST)重症监护委员会发布了横纹肌溶解症共识文件。横纹肌溶解症的特征是骨骼肌破坏，细胞内物质释放到血液中，包括电解质、酶和肌红蛋白，导致全身并发症。

中文标题：

2022 AAST临床共识：横纹肌溶解症

英文标题：

Rhabdomyolysis: an American Association for the Surgery of Trauma Critical Care Committee Clinical Consensus Document

发布机构：

美国创伤外科协会

发布日期：

2022-01-27

简要介绍：

2022年1月，美国创伤外科协会(AAST)重症监护委员会发布了横纹肌溶解症共识文件。横纹肌溶解症的特征是骨骼肌破坏，细胞内物质释放到血液中，包括电解质、酶和肌红蛋白，导致全身并发症。本文主要介绍了横纹肌溶解症的当前诊断、治疗和预后的相关内容。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2022 AAST临床共识：横纹肌溶解症.pdf)] GetToolGuiderByIdResponse(projectId=1, id=fbad41c0023a9e91, title=2022 AAST临床共识：横纹肌溶解症, enTitle=Rhabdomyolysis: an American Association for the Surgery of Trauma Critical Care Committee Clinical Consensus Document, guiderFrom=Trauma Surg Acute Care Open, authorId=0, author=, summary=2022年1月，美国创伤外科协会(AAST)重症监护委员会发布了横纹肌溶解症共识文件。横纹肌溶解症的特征是骨骼肌破坏，细胞内物质释放到血液中，包括电解质、酶和肌红蛋白，导致全身并发症。, cover=https://img.medsci.cn/2022210/1644500375202_1608702.jpg, journalId=0, articlesId=null, associationId=2067, associationName=美国创伤外科协会, associationIntro=美国创伤外科协会(AAST,American Association for the Surgery of Trauma), copyright=0, guiderPublishedTime=Thu Jan 27 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2022年1月，美国创伤外科协会(AAST)重症监护委员会发布了横纹肌溶解症共识文件。横纹肌溶解症的特征是骨骼肌破坏，细胞内物质释放到血液中，包括电解质、酶和肌红蛋白，导致全身并发症。本文主要介绍了横纹肌溶解症的当前诊断、治疗和预后的相关内容。</span></p>, tagList=[TagDto(tagId=3298, tagName=横纹肌溶解症)], categoryList=[CategoryDto(categoryId=14, categoryName=肾内科, tenant=100), CategoryDto(categoryId=38, categoryName=急重症, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7814, appHits=221, showAppHits=0, pcHits=2210, showPcHits=7589, likes=1, shares=29, comments=8, approvalStatus=1, publishedTime=Fri Feb 11 15:37:00 CST 2022, publishedTimeString=2022-01-27, pcVisible=1, appVisible=1, editorId=0, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=dajiong, createdTime=Thu Feb 10 21:42:21 CST 2022, updatedBy=1608702, updatedName=dajiong, updatedTime=Sat Jan 06 22:01:34 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2022 AAST临床共识：横纹肌溶解症.pdf)])
2022 AAST临床共识：横纹肌溶解症.pdf
下载请点击：
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2151994, encodeId=b360215199455, content=认真学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/31/336654fd3011b8b7bea05920e78968a6.jpg, createdBy=57f12186076, createdName=小雨的大侠, createdTime=Wed Aug 09 21:27:20 CST 2023, time=2023-08-09, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2090666, encodeId=faef20906668d, content=非常有指导, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc435475929, createdName=ms1000000861491970, createdTime=Tue Sep 27 17:02:31 CST 2022, time=2022-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231419, encodeId=044b12314191b, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210504/116df3262c634217bbc376074dc37be6/0208a35cf34f402bb00734729cf58466.jpg, createdBy=4f5b5487126, createdName=ms8000000886330414, createdTime=Fri Jul 08 23:57:10 CST 2022, time=2022-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200230, encodeId=88bc1200230b0, content=学, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22a95451577, createdName=ZY-WS-LP, createdTime=Mon Mar 07 14:45:38 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196572, encodeId=3da111965e28f, content=认真学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=149b6419153, createdName=ms6000001109335715, createdTime=Wed Feb 23 21:50:03 CST 2022, time=2022-02-23, status=1, ipAttribution=)]
    2023-08-09 小雨的大侠 来自安徽省

    认真学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2151994, encodeId=b360215199455, content=认真学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/31/336654fd3011b8b7bea05920e78968a6.jpg, createdBy=57f12186076, createdName=小雨的大侠, createdTime=Wed Aug 09 21:27:20 CST 2023, time=2023-08-09, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2090666, encodeId=faef20906668d, content=非常有指导, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc435475929, createdName=ms1000000861491970, createdTime=Tue Sep 27 17:02:31 CST 2022, time=2022-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231419, encodeId=044b12314191b, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210504/116df3262c634217bbc376074dc37be6/0208a35cf34f402bb00734729cf58466.jpg, createdBy=4f5b5487126, createdName=ms8000000886330414, createdTime=Fri Jul 08 23:57:10 CST 2022, time=2022-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200230, encodeId=88bc1200230b0, content=学, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22a95451577, createdName=ZY-WS-LP, createdTime=Mon Mar 07 14:45:38 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196572, encodeId=3da111965e28f, content=认真学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=149b6419153, createdName=ms6000001109335715, createdTime=Wed Feb 23 21:50:03 CST 2022, time=2022-02-23, status=1, ipAttribution=)]
    2022-09-27 ms1000000861491970

    非常有指导

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2151994, encodeId=b360215199455, content=认真学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/31/336654fd3011b8b7bea05920e78968a6.jpg, createdBy=57f12186076, createdName=小雨的大侠, createdTime=Wed Aug 09 21:27:20 CST 2023, time=2023-08-09, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2090666, encodeId=faef20906668d, content=非常有指导, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc435475929, createdName=ms1000000861491970, createdTime=Tue Sep 27 17:02:31 CST 2022, time=2022-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231419, encodeId=044b12314191b, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210504/116df3262c634217bbc376074dc37be6/0208a35cf34f402bb00734729cf58466.jpg, createdBy=4f5b5487126, createdName=ms8000000886330414, createdTime=Fri Jul 08 23:57:10 CST 2022, time=2022-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200230, encodeId=88bc1200230b0, content=学, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22a95451577, createdName=ZY-WS-LP, createdTime=Mon Mar 07 14:45:38 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196572, encodeId=3da111965e28f, content=认真学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=149b6419153, createdName=ms6000001109335715, createdTime=Wed Feb 23 21:50:03 CST 2022, time=2022-02-23, status=1, ipAttribution=)]
    2022-07-08 ms8000000886330414

    👍

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2151994, encodeId=b360215199455, content=认真学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/31/336654fd3011b8b7bea05920e78968a6.jpg, createdBy=57f12186076, createdName=小雨的大侠, createdTime=Wed Aug 09 21:27:20 CST 2023, time=2023-08-09, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2090666, encodeId=faef20906668d, content=非常有指导, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc435475929, createdName=ms1000000861491970, createdTime=Tue Sep 27 17:02:31 CST 2022, time=2022-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231419, encodeId=044b12314191b, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210504/116df3262c634217bbc376074dc37be6/0208a35cf34f402bb00734729cf58466.jpg, createdBy=4f5b5487126, createdName=ms8000000886330414, createdTime=Fri Jul 08 23:57:10 CST 2022, time=2022-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200230, encodeId=88bc1200230b0, content=学, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22a95451577, createdName=ZY-WS-LP, createdTime=Mon Mar 07 14:45:38 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196572, encodeId=3da111965e28f, content=认真学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=149b6419153, createdName=ms6000001109335715, createdTime=Wed Feb 23 21:50:03 CST 2022, time=2022-02-23, status=1, ipAttribution=)]
    2022-03-07 ZY-WS-LP

    学

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2151994, encodeId=b360215199455, content=认真学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/31/336654fd3011b8b7bea05920e78968a6.jpg, createdBy=57f12186076, createdName=小雨的大侠, createdTime=Wed Aug 09 21:27:20 CST 2023, time=2023-08-09, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2090666, encodeId=faef20906668d, content=非常有指导, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc435475929, createdName=ms1000000861491970, createdTime=Tue Sep 27 17:02:31 CST 2022, time=2022-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231419, encodeId=044b12314191b, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210504/116df3262c634217bbc376074dc37be6/0208a35cf34f402bb00734729cf58466.jpg, createdBy=4f5b5487126, createdName=ms8000000886330414, createdTime=Fri Jul 08 23:57:10 CST 2022, time=2022-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200230, encodeId=88bc1200230b0, content=学, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22a95451577, createdName=ZY-WS-LP, createdTime=Mon Mar 07 14:45:38 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196572, encodeId=3da111965e28f, content=认真学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=149b6419153, createdName=ms6000001109335715, createdTime=Wed Feb 23 21:50:03 CST 2022, time=2022-02-23, status=1, ipAttribution=)]
    2022-02-23 ms6000001109335715

    认真学习

    0

相关指南

2021 EAST实践指南：横纹肌溶解症的管理

美国东部创伤外科学会(EAST,The Eastern Association for the Surgery of Trauma) · 2021-10-05